market-trends is the sole category represented across all 1 tracked stories. Brisbane Times is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 3.1 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Therapeutic Goods Administration
market-trends is the sole category represented across all 1 tracked stories. Brisbane Times is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 3.1 for the broader beat in this window. At 7, the average consequence score sits above the same-window beat average of 6.3. Therapeutic Goods Administration appears in 1 tracked Healthcare story from March 17, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 34 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Therapeutic Goods Administration. Shared-story counts are live from our verified record — not editorial picks.
A landmark study published in The Lancet has concluded that medicinal cannabis is no more effective than a placebo in treating anxiety, depression, and PTSD. The findings challenge the multi-billion dollar cannabis industry's reliance on mental health prescriptions and could trigger significant regulatory shifts.
Therapeutic Goods Administration is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.